Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Breast Neoplasms 90Triple Negative Breast Neoplasms 18Stomach Neoplasms 14Inflammatory Breast Neoplasms 12Esophageal Neoplasms 7Lymphoma, Large B-Cell, Diffuse 5Testicular Neoplasms 3Pancreatic Neoplasms 3Lymphoma 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2pCR Rate 1Women With Primary Breast Cancer 1Upper Tract Urothelial Carcinoma 1Unilateral HER2 Positive Breast Cancer 1Thymoma 1Testicular Germ Cell Tumor 1Small Cell Lung Cancer Extensive Stage 1Rare Tumour 1Prostatic Neoplasms 1Primary Breast Cancer 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Ifosfamide 4Doxorubicin 4Imatinib Mesylate 3Filgrastim 3brostallicin 2Vincristine 2Sunitinib 2Radiotherapy 2Radiation Dose Hypofractionation 2Etoposide 2Dactinomycin 2Cyclophosphamide 2Carboplatin 2temsirolimus 1soblidotin 1saracatinib 1romidepsin 1reolysin 1perifosine 1pazopanib 1exatecan 1etoposide phosphate 1cixutumumab 1Trabectedin 1Topotecan 1Thiotepa 1Temozolomide 1Surgical Procedures, Operative 1Sirolimus 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fibrosarcoma × Epirubicin × Clear all
NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡